operated by קבוצת הרפואה של סיידמן
operated by קבוצת הרפואה של סיידמן
Proudly Greek, European & Jewish
Founded by Dr. Marius Lazar in Greece because he had found the love of his life there, LCG was later acquired and has become a part of the Jewish Seideman(n) family dynasty, with Marius and his own team still on board. The EU HQ is in central Athen, small regional offices are to be found around the globe: LCG is a proud Jewish-Greek institution in the European Union.
Educating the next generation
Teaching medicine on three continents in many different fields and settings. The focus is on 'rare diseases', an area for which we care passionately. Some member of LCG and the Seideman Group are - independently of their function with LCG active supporters of the Jewish University (JUC), the only higher messianic Jewish educational institution globally.
Rare disease experts
We are running the only international network practice, LAZAR | SEIDEMAN | SMITH, for the treatment of rare neurologic, neuroendocrinologic, and neurometabolic conditions. The international network practice offers 51 longterm treatment places in cooperation with local partners worldwide. In addition, it helps an average of another 400 to 600 colleagues worldwide with the treatment of rare diseases through medical consultations.
Minority interest management
Walter Seideman is the legal representative of LCG and its minority holdings, the primus inter pares, and a seasoned physician.
Embracing Change, Pioneering Innovation – The Lazar Medical Consortium Group - LCG
LCG Research takes pride in the positive feedback received for its non-profit Amitradicain composite formula, the first sympathicolytic drug which stimulates quite strongly also the so called called "parasympathetic nervous system".
Dr. Adrian Tudor, who collaborates as a freelance colleague with LCG Group and various other organizations, has recently acquired the former LCG subsidiary, CLINICO. We extend our heartfelt wishes for success to him and his team.
Due to the ongoing war against Israel, our Tel Aviv office will remain closed until further notice. As LCG has a majority of Jewish employees, we are committed to their safety and well-being. Following the conclusion of the conflict, we plan to open a small branch in Samaria to be also present in central Israel.
We are where you are.
Thanks to a close and trustful cooperation with partners all over the world, LCG and the Seideman Group can be there for you - wherever you are (countries with local LCG representatives are marked in purple on the map).
The Seideman Medical Group
A global network
The Seidemann(s), the second "n" is a transliteration issue caused by the authorities of some countries, are a cosmopolitan family, small but with a long tradition line in the fields medicine, art, and patronage. We are liberal Jews, messianic Jews, some converted to other religions, or became agnostics. However, we believe in behavior and results only, not labels or politics.
We are connected by heritage and love, with relatives on every continent except Antarctica. But even that can change, because a true Seideman knows only the limits of ethics and morality. The rest can and should be explored. This website is for contacting those Seidemans who have found their mission in medicine.
It was prompted by the 2022 takeover of the Lazar Medical Consortium Group by the Seideman Group and some long-time partners, some of whom wish to introduce themselves publicly, others not.
"Being a Seideman means never leaving someone behind."
Proud to endorse
The Jewish University
The Jewish University (JUC) in Denver, CO, is the only messianic Jewish institution of higher education. It's been a proud and fully independent institution since 1980. However, LCG Seideman grants JUC to use the international Lazar | Seideman | Smith network-practice as its clinical teaching center.
JUC - International Rare Disease Practice Network
Grassroot research team by Dr. Diamandis
Denver, Athens, Luxembourg, Madrid et al.
Leading the Clinician to Clinian program
Dr. Rosenberg (platform supported example)
your-doctor.org™
Trans-European Healthcare
LCG Asia Pacific
In the process of being sold
Sometimes, small stakes keep big things afloat
NGO (non-profit, Europe) by Mrs. Lazar
LCG Brazil
Soon to be available
CLINICO™
Telemedservice for the entire EU
Wait a second...
isn't it true?
“He who has health has hope; and he who has hope, has everything.”
– Thomas Carlyle
Health @ LCG
for the forgotten ones with rare diseases.
The Lazar Medical Consortium Group (LCG) run by the Seideman family and Dr. Marius Lazar is an association (Art. 78 GR CV) which coordinates the activities of its members and represents them to the outside world. It serves as a "single point of contact" that facilitates contact with the ramified network of projects run by Dr. Marius Lazar and/or the Seideman family. Unlike its members, the LCG association itself is not active in any form of medical, teaching and/or entrepreneurial activities.
Network
The digital world has greatly changed medicine, as well as teaching, research, etc. - Dr. Marius Lazar recognized this at an early stage and has since acted more quickly and flexibly in medicine, social commitment, but also in research and teaching through his networks. In addition, he has always included other colleagues in his consortium who would not have dared to take the step into the digital world without his digital expertise.
Why a reorganization?
A reorganization did never take place, and none is planned. What will be changed in the fall of 2022 is the external presentation, so that everyone can understand more easily and quickly what the LCG members do and how to reach them. Since all LCG members are medical professionals, this is managed by PlusOne Media as the communications service provider of LCG.
SENIOR LCG MEMBERS & OTHER HONORARY SEIDEMANS
Dr. Carolina Diamandis
DIRECTOR GENERAL OF LCG RESEARCH
Prof. Dr. David Seideman
MEDICAL DIRECTOR OF THE LCG GROUP | LECTURER
Dr. Marius Lazar
FOUNDER OF THE LCG GROUP & LUZIA HEALTHCARE
Dr. Lucas Smith
VICE DIRECTOR OF THE LCG GROUP
Dr. Alexandros Balaskas
HEAD OF QUALITY MANAGEMENT THE LCG GROUP
Rachel Seideman
LEGAL & COMPLIANCE MANAGER OF THE LCG GROUP
Dr. David Alexander Seideman
THE SEIDEMAN WHO'S IN CHARGE IF INDIA & MALAYSIA
INTERNIST | GP | DIAGNOSTICIAN
Alicia Popescu
CHIEF ASSISTANT OF THE DIRECTORATE OF LCG
Walter Seideman
THE ONE WHO HAS AN EYE ON ALL THAT HAPPENS
Melissa Jones
HEAD OF OPERATIONS CLINICO AND LCG ASIA
Other Senior Members
NOTABLE LCG / TEAM SEIDEMAN MEMBERS
Seideman or Seidemann?
Get a super short lesson in Jewish history.
Seideman?
Seidemann?
No Seide no Man?
Honorary Seidemans?
Welcome to LCG Research
LCG Research is the grassroots research department of the Seideman Medical Group
Why LCG Research is needed
From Clinicians for clinicians.
Fast spread of new findings using latest technology
We believe that important discoveries in medicine progress far too slowly from the researcher to everyday life of clinicians around the globe. Therefore, LCG Research was established under the leadership of Dr. Carolina Diamandis and Professor Dr. Seideman. The main difference to other research institutions, besides the lack of pursuit of profit, is the focus on publications on digital academic channels and collaborations with independent researchers worldwide.
Peer-to-peer learning is a mutual learning and training strategy that involves participants of the same level engaging in collaborative learning. It can provide an opportunity for learners to share and discuss diverse perspectives, leading to a more well-rounded understanding of the topic. Benefits of peer-to-peer learning include increased engagement and performance, as well as the ability to learn new skills and knowledge.
Get in touch
We will gladly anwer.
ADMINISTRATION
LCG Greece
on behalf of LCG Intl.
16 Kifissias Avenue
115 26 Athens
Hellenic Republic
European Union
PHONE
+30 21 123447-27
administration@lazar-consortium.com
LEGAL DEPARTMENT
P.0. Box 11OO7
Fort Lauderdale, FL
33339
United States of America
legal@lazar-consortium.com
© Made and run for LCG by PlusOne Media (2023)